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Abstract
Background: Inherited and acquired retinal degenerations are frequent causes of visual impairment and photoreceptor cell
replacement therapy may restore visual function to these individuals. To provide a source of new retinal neurons for cell
based therapies, we developed methods to derive retinal progenitors from human ES cells.
Methodology/Physical Findings: In this report we have used a similar method to direct induced pluripotent stem cells (iPS)
from human fibroblasts to a retinal progenitor fate, competent to generate photoreceptors. We also found we could purify
the photoreceptors derived from the iPS cells using fluorescence activated cell sorting (FACS) after labeling photoreceptors
with a lentivirus driving GFP from the IRBP cis-regulatory sequences. Moreover, we found that when we transplanted the
FACS purified iPSC derived photoreceptors, they were able to integrate into a normal mouse retina and express
photoreceptor markers.
Conclusions: This report provides evidence that enriched populations of human photoreceptors can be derived from iPS
cells.
Citation: Lamba DA, McUsic A, Hirata RK, Wang P-R, Russell D, et al. (2010) Generation, Purification and Transplantation of Photoreceptors Derived from Human
Induced Pluripotent Stem Cells. PLoS ONE 5(1): e8763. doi:10.1371/journal.pone.0008763
Editor: Rafael Linden, Universidade Federal do Rio de Janeiro (UFRJ), Brazil
Received October 5, 2009; Accepted December 24, 2009; Published January 20, 2010
Copyright:  2010 Lamba et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by a gift from an anonymous donor and support from the Foundation Fighting Blindness (TA-CBT-0608-0464-UWA-EW and TA-
CBT-0507-0377-UWA) and National Institute of General Medical Sciences (NIGMS) 5P01GM081619 to T.A.R, National Institutes of Health (NIH) funds to D.W.R and a
National Science Foundation (NSF) Fellowship to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: Thomas A. Reh is on the Editorial Board of PLoS ONE.
* E-mail: tomreh@u.washington.edu
Introduction
Retinal degenerations that involve rod and cone photoreceptors
are a major cause of blindness, and affect millions of people in the
US. These devastating conditions can be inherited or acquired,
and while efforts are underway to develop treatments that slow or
prevent these conditions using gene therapy or medical treatments,
once the photoreceptors have degenerated, cell replacement or
prosthetic devices are the only options. Cell replacement of
photoreceptors has been shown to be feasible, even in mature
mice, where photoreceptors transplanted to the sub-retinal space
can integrate into the retina and function [1,2]. We, and others,
have developed protocols for generating retinal progenitors and
photoreceptors from human embryonic stem cells as a potential
source of replacement photoreceptors for cell-based therapy of
retinal degenerations [3,4,5]. Our protocol involves the directed
differentiation of undifferentiated human embryonic stem (hES)
cells into retinal progenitor cells, followed by expansion of these
cells and their differentiation into photoreceptors. These cells can
be transplanted to the sub-retinal space of visually deficient mice
and can restore some light response [2].
One of the problems with cell-based therapies is that recipients
may require immuno-suppressant drugs to prevent rejection of
the transplanted cells. One way around this complication is to
use cells derived from closely related or HLA-matched
individuals or even the patients themselves, using induced
pluripotent stem cells (iPS). iPS cells were initially generated
by Shinya Yamanaka and colleagues by expressing combinations
of candidate genes into mouse embryonic fibroblasts [6]. The
four genes that were required, OCT3/4, SOX2, KLF4 and c-MYC
have also been shown to induce pluripotency in human
fibroblasts, and various combinations of these and small
molecules can efficiently induce the pluripotent state in a variety
of different cell types [6,7,8,9,10,11]. The iPS cells behave
similarly to ES cells in most assays, including contributing to
mouse germline transmission [9]. Several groups have shown
that iPS cells can be directed to a variety of lineages and may be
useful for studying specific diseases where animal models do not
exist or are inadequate (eg. [12]).
The similarity of iPS cells to hES cells led us to ask whether
these cells would respond to our retinal determination protocol like
the ES cells. In this report we show that iPS cells, generated with
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directed to a retinal progenitor fate using the same protocol as we
developed for hES cells. Moreover, we show for the first time that
iPSC-derived photoreceptors can be identified in the cultures by
infection with a viral construct in which GFP is driven from a
photoreceptor-specific (IRBP) promoter. The GFP+ photorecep-
tors can be highly purified using FACS, providing a potentially
unlimited source for cell-based therapies of retinal degenerations.
Lastly, we show that the iPSC-derived photoreceptors that have
been purified by FACS integrate into the outer nuclear layer after
transplantation to the sub-retinal space of adult mice, similar to
normal mouse photoreceptors and ES cell derived rod photore-
ceptors. The ability to derive retinal photoreceptors from iPS cells
will also be useful in the development of in vitro models of specific
human retinal degenerations.
Materials and Methods
Cell Culture and Retinal Induction
H-1 (WA01) line was obtained from Wicell, the Hues6, Hues14
and Hues16 were obtained from Doug Melton (Harvard
University, MA) and Mel1 and Mel2 lines were purchased from
Millipore. An iPS cell line was made by infecting a human
fibroblast culture (Coriell GM05387) with lentiviral vectors
expressing OCT4, NANOG, LIN28 and SOX2 as described
[11]. All cell lines were initially maintained with CF-1 feeders and
subsequently adapted to feeder-free conditions. Retinal induction
was performed by modifying the protocol previously described [5].
Instead of making embryoid bodies, 25–30 of the 150–200 ES cell
clumps were plated on Matrigel coated 35mm dishes and cultured
for 3 days in the presence of mouse noggin (1 ng/ml, R&D
Systems), human recombinant Dkk-1 (1 ng/ml, R&D Systems)
and human recombinant insulin-like growth factor-1 (IGF-1)
(1 ng/ml, R&D Systems). From the fourth day, the concentration
of the factors was increased to 10 ng/ml. The media was changed
every 2–3 days for up to three weeks. The cells were cultured for
several months in media containing N2 and B27 supplement
without any additional factors for further differentiation.
Immunocytochemistry and Immunohistochemistry
Cells and eyes were fixed with 4% paraformaldehyde and
analyzed with the following antibodies using protocol previously
described: rabbit anti-recoverin (gift from Dr. Jim Hurley,
University of Washington, 1:1000), mouse anti-Hu C/D (Molec-
ular Probes, 1:200), mouse anti-rhodopsin (Rho-4D2) (gift from
Dr. Molday, University of British Columbia, 1:750), mouse anti-
Pax6 (1:250) and mouse anti-SSEA4 (1:10) (DHSB), mouse anti-
human a-SMA, mouse anti-human AFP and mouse anti-MAP2
(Millipore), chicken anti-GFP (1:500) and rabbit anti-Sox9 (1:400)
(Abcam), rabbit anti-S-opsin (gift from Dr. J Nathans, Johns
Hopkins University, 1:1000), rabbit anti-Nrl (gift from Dr. A.
Swaroop, 1:500), goat anti-Otx2-biotin (R&D Systems, 1:250),
rabbit anti-AIPL1 (gift from Dr. V. Ramamurthy, 1:5000), rabbit
anti-Crx (gift from Dr. C. Craft, 1:250), rabbit anti-ZO-1
(Invitrogen, 1:250), goat anti-Sox2 (1:500), goat anti-Oct3/4
(1:250), goat anti-Brn3 (1:100) and rat anti-Blimp1 (1:100) (Santa
Cruz). Secondary antibody staining was done using the corre-
sponding Cy5 (Jackson Immunoresearch), Cy5-conjugated strep-
tavidin, Alexa-488, Alexa-568, and Alexa 633 fluorescent-
conjugated antibodies (Invitrogen, 1:500). The primary antibodies
were used at the appropriate dilution in 0.5% Triton X-100 and
5% dry milk in PBS overnight at 4uC. The slides were then
washed 3 times in PBS followed by 1 hour in secondary antibody
at room temperature. Images were taken using a Nikon A1
confocal microscope. Image analysis was performed using Volocity
software (Improvision) and Adobe Photoshop CS4. All counts
shown as mean +/2 SEM.
Virus Production and Infection
EF-1a-GFP lentivirus was made using constructs provided by
Dr. Charles Murry (University of Washington). The IRBP-GFP
lentivirus was prepared using the human IRBP promoter from Dr.
Paul Overbeek (Baylor College of Medicine, TX). pRRL-cPPT-
CMV lentivirus plasmid was cut to remove the CMV promoter
and replaced with the multiple cloning site and the eGFP portion
from pEGFP1 plasmid (Clonetech). The human IRBP promoter
was next subcloned into the multiple cloning site to drive eGFP
expression. Both lentiviruses are 3rd generation replication-
incompetent lentivirus and were made using the four-plasmid
system as previously described [2]. The ES cultures were infected
with either the EF-1a lentivirus or the IRBP-GFP lentivirus from
four to eight weeks after the induction of retinal determination,
and were maintained for an additional one to two weeks to allow
for expression of the GFP.
Fluorescent Activated Cell Sorting (FACS)
To isolate the cells that express IRBP-GFP from the ES
cultures, we dissociated them into a single-cell suspension using
trypsin. Prior to sorting, aggregates were removed by passing
through a 40 mm cell strainer. FACS was carried out on BD Aria
II sorter, gated for a high level of GFP expression.
Explant Culture
Retinas from newborn mouse, embryonic day 4 chicken, and 82
day, and 90 96 day fetal human retinas (obtained from the
Laboratory of Developmental Biology - NIH HD 000836 at the
University of Washington without identifiers) were dissected from
extra-ocular tissues and cultured in the presence of IRBP-GFP
lentivirus as free-floating explants in ultra-low attachment plates
overnight. The media was then changed and the explants were
maintained for an additional four days, prior to fixation with 4%
PFA and cryosectioning. One of the fetal human retinas was fixed
for cryosectioning while the other was trypsinized and used for
FACS and microarray analysis.
Real Time Quantitative PCR Analysis
Total RNA was extracted from the cultures using TriZol
(Invitrogen) followed by chloroform extraction as per manufac-
turer’s instructions. This was followed by DNAse-1 (Qiagen)
treatment followed by RNA cleanup using Qiagen RNA mini
cleanup kit. cDNA was reverse transcribed using Superscript II
RT kit (Invitrogen) as per manufacturer’s instructions. Q-PCR was
performed for various genes as previously described [5] and results
normalized to b2actin levels.
Microarray Analysis
For microarray analysis, a 96 day human fetal retina and FACS
purified human fetal photoreceptors were lyzed in Trizol and
RNA extracted as described above. The RNA was then checked
for RNA integrity and run as per manufacturer’s guidelines on the
Human Gene 1.0 ST chip (Affymetrix). The data was then
normalized in the GCOS software and was then analyzed using
Multi-Experiment Viewer (v. 4.4) software.
Cell Transplantation
All experiments were done in accordance with approved
protocols and the animals were housed and bred in the
iPS Cells Make Photoreceptors
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Washington. To test whether the iPSC-derived photoreceptors
could integrate into normal retina, adult wild-type mice were
anesthetized and approximately 50,000 FACS purified iPSC
derived photoreceptors were injected into the sub-retinal space as
previously described [2]. Animals that received injections of iPSC
derived photoreceptors also received daily injections of the
immunosuppressant Cyclosporine A (10 mg/kg/day). After sur-
vival periods of two to three weeks, the animals were sacrificed, the
retinas removed, cryosectioned and processed for immunofluores-
cent analysis. To determine whether the undifferentiated iPSCs
could generate teratomas, we carried out the assays as described in
a previous publication [13].
Results
The iPS cells were generated from normal human fibroblast
cultures as described previously (Yu et al., 2007) with lentiviral
vectors expressing OCT4, NANOG, LIN28 and SOX2. Upon
quadruple infection, several human ESC-like colonies appeared
after three weeks and were isolated and expanded further. One
particular clone (iPSC-MHF2 c1) was chosen for our experiments.
When cultured, these cells expressed the pluripotency markers
SOX2, OCT4 and SSEA-4 (figure 1A-A09). The cells could be
maintained with CF-1 feeder layers as well as in feeder-free MEF-
conditioned media. In vivo, the iPS cells were capable of
differentiation into cells of all three germ layers upon teratoma
formation in immunodeficient mice (Figure 1B, C, D), confirming
that the iPSCs were pluripotent. Additionally, we looked for
silencing of exogenous pluripotency genes and found that even
though Nanog and Lin28 were silenced, there was still some
expression of lentivirus induced Oct4 and Sox2 (Supplemental
Figure S2).
Next we tested whether these cells could be directed to a retinal
fate using a modification of our previously published protocol (see
Methods). The undifferentiated iPS cells were plated on Matrigel-
coated plates and treated with Dkk-1, IGF-1 and Noggin for three
weeks. As described in our previous report [5], the efficiency of
retinal determination was tested by analyzing the expression of
several key eye-field transcription factors (EFTFs) using RT-PCR.
All the EFTFs that we analyzed, Pax6, Six3, Lhx2 and Rx, showed
a 6 to 10 cycle (80 to 1000 fold) increase over the undifferentiated
cells at the end of two weeks of retinal induction (figure 2A). This is
similar to that which we observed using the H1 human ES cell line
(Lamba et al, 2006). In addition, there was on an average 5 cycle
(34-fold) increase in expression of Crx at end of 2 weeks (figure 2A).
We also analyzed the time course of the gene expression over 5
weeks of differentiation (Figure 2 E,F). We found that while the key
EFTFs Pax6, Lhx2 and Rx showed a rapid and sustained up-
regulation over the course of the experiment, the ‘‘late’’ progenitor
marker, Ascl1 showed a much slower increase, with a peak at three
weeks (Figure 2E). While these changes were similar to those we
have previously reported from ES cells subjected to this protocol
[5], the expression of Six3, another EFTF, was somewhat different
in the iPSCs than what we have observed in the ES cells. Six3
shows an early peak, like the other EFTFs, but then declines over
the next few weeks. We don’t have an explanation for this
difference, though it may be that ineffective silencing of the
transgenes in the iPSCs (see above) may interfere with Six3
expression. We also analyzed the expression of the photoreceptor
markers, Crx, recoverin and Nrl. All of these increased in the
iPSCs as a function of time of treatment (Figure. 2F), albeit with
somewhat different time courses. The pan-photoreceptor gene,
Crx, showed early increases, while recoverin, a later photoreceptor
marker of rods and cones, and Nrl, a rod photoreceptor
transcription factor, increased after progressively longer periods
of culture.
Since recent reports have shown substantial variability in the
response of different ES and iPSC lines to directed differentiation
protocols, we tested the effectiveness of this retinal determination
protocol on a number of other human ES cell lines and one of the
other iPS cell clone iPSC-MHF2 c2. These included three
Harvard hES cell lines by Doug Melton’s lab (Hues6, Hues14
and Hues16), and two Australian hES cell lines available through
Millipore (Mel1 and Mel2). These cells were also cultured using
the retinal determination protocol and analyzed for expression of
the EFTFs at the end of two weeks. Overall, each of the lines
responded to the induction protocol similarly to the H1 line;
however, there were small variations in the expression levels of the
EFTFs, as well as Crx, among the different cell lines. This was
particularly evident in the case of the iPSC-MHF2 c2 line
(Figure 2A), which showed much less effective induction of retinal
genes than any of the other lines. Together with the results from
the iPSCs, these data show the robustness of the protocol in
creating retinal progenitors from various human ES as well as iPS
cells.
To confirm the RT-PCR analysis, we analyzed the retinal cells
created from human iPS cells by immunocytochemistry for
expression of various retinal markers. Retinal progenitors express
Pax6, Sox2 and Sox9. We found that at the end of three weeks
all three markers were co-expressed by the iPSCs that had been
directed to a retinal fate (figure 2C-C09). Overall by three weeks
70.22% (+/25.24) of the cells expressed Pax6, 69.89% (+/
25.01) expressed Sox2 and 71.09% (+/24.69) expressed Sox9.
Most cells also expressed the neural progenitor marker nestin
(figure 2D, D’). The culture plates also had patches of retinal
pigmented epithelial cells, displaying pigmentation, characteris-
tic hexagonal morphology and ZO-1 expression (figure 2D, D0,
3H). Other cells in the cultures expressed markers of inner
Figure 1. Co-expression of undifferentiated cell markers Sox2
(green, A9), SSEA-4 (blue, A0) and Oct4 (red, A09) by iPS cells
with merged view in (A). (B-D) Tri-lineage potential of teratomas
formed by iPSC-MHF2 c1 in immunodeficient mice. Histological sections
from a teratoma stained with antibodies against human MAP-2
(microtubule associated protein-2, B), human SMA (alpha smooth
muscle actin, C), or human AFP (alpha-fetoprotein) and co-stained with
DAPI (blue).
doi:10.1371/journal.pone.0008763.g001
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and ganglion cells and Brn3 which labels ganglion cells
(figure 2D, D09). We also analyzed the cells for markers for
photoreceptor differentiation at the end of 2 months of
induction. The cells in the retinal directed iPS cell cultures
expressed the pan-photoreceptor markers Otx2 (9.6% (+/2
1.13%)) (figure 3B) and Crx (11.8% (+/22.9%)) (figure 3E). Cells
also express the rod photoreceptor-specific transcription factor
Nrl (figure 3A) and that 29.7% (+/22.3%) of all photoreceptors
were rod photoreceptors. Markers of more differentiated
photoreceptors such as recoverin, AIPL-1, rhodopsin and S-
opsin (figure 3C,D, G, F respectively) were expressed by less than
1% of cells at 2 months. These data were confirmed by PCR for
expression of Crx, Nrl, arrestin, recoverin, Trb2, rhodopsin and
Pax6 (Figure 2B). Thus, human iPS cells can be induced into
retinal fate and these cells express markers of retinal progenitors
as well as differentiated cells such as ganglion cells, amacrine
cells and photoreceptor cells.
Figure 2. (A) RT-PCR comparison of expression of EFTFs and CRX in the various human ES and iPS cell lines expressed as a cycle
change in PCR expression level compared to undifferentiated cells (n=3–6) for the various lines, error bars represent SEM. (B) Gel
showing expression of retinal markers by RT-PCR following retinal induction of iPS cells. (C) Co-expression of Pax6 (white, C, C9), Sox2 (green, C, C0),
and Sox9 (red, C, C09) by iPS cell derived retinal progenitors (merged in (C)) at the end of three weeks. The progenitors also expressed nestin (white,
D,D’) in the typical rosette pattern with ZO-1(green, D, D0) in the center and Brn3 expressing ganglion cells (red, D, D09) at the periphery. (E, F) RT-PCR
graph showing time course of expression of various retinal progenitor cell (E) and photoreceptor cell (F) genes over the course of 5 weeks. Error bars
represent SEM.
doi:10.1371/journal.pone.0008763.g002
iPS Cells Make Photoreceptors
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retinal cells will need to be further purified from contaminating
cell populations. One approach that has been used successfully in
other regions of the nervous system is to use cell-type specific
promoters coupled with fluorescent activated cell sorting (FACS).
Inter-photoreceptor retinol binding protein (IRBP) is a photore-
ceptor specific gene expressed by both rod and cone photorecep-
tors early in their development prior to outer segment formation
[14]. The human IRBP promoter has been shown to drive
photoreceptor-specific expression in transgenic mice [15]. We
constructed a lentivirus expressing GFP from the human IRBP
promoter, and tested the specificity using human, mouse and
chicken retinal explants. The IRBP-GFP lentivirus resulted in
GFP expression only in the outer nuclear layer of all three species
where the photoreceptors reside (Figure 4 and Supplementary
Figure S1). Upon co-staining the human retinas for various
photoreceptors markers including recoverin, Otx2, Blimp-1 and
AIPL1, we found that GFP co-localized with photoreceptors in the
retinas infected with IRBP-GFP (figure 4A–D). As a control for the
specificity of infection, we used an EF1a lentivirus to infect other
retinal explants; in these cases GFP was expressed in all of the
various retinal cell types (Supplementary Figure S1). Thus,
lentivirus with the human IRBP promoter driving GFP,
specifically results in expression of GFP in photoreceptors of
human, mouse and chicken retinas.
To test the ability to enrich photoreceptors, we infected 90 day
fetal human retinal explants for 4 days in vitro and then
dissociated the retinas. The dissociated cells were then subjected
to fluorescent activated cell sorting (FACS). Following FACS, the
cells were lysed in Trizol and RNA collected and used to run the
Human Gene 1.0 ST array chip. We compared the results from
the Affymetrix analysis of mRNA from FACS enriched photore-
ceptors to that from mRNA from a similarly staged (96 day)
human fetal retina (GEO Accession # GSE18487). We found that
many photoreceptor genes including PDE6C, GNAT2, PDE6H,
THRB, RPGRIP1, CRX, ABCA4, RS1, TULP1, GNB3, EYS,
IMPG2, PCDH21, USH2A, CNGA3, NEUROD1 and RCVRN
were higher in the mRNA from the FACS purified photorecep-
tors, while progenitor genes like PAX6, LHX2, NESTIN, HES1,
HES5, HEY1, HEY2 and SOX9 showed lower levels of
expression when compared to mRNA from the 96 day fetal retina
(figure 5). Thus, the microarray data confirmed that the IRBP-
GFP resulted in photoreceptor specific GFP expression and that
the cells can be enriched using FACS.
Retinal cells derived from iPS cells or H-1 hES cells were then
infected with the IRBP-GFP lentivirus 4 to 8 weeks after initiation
of the retinal induction protocol. Based on our previous work using
a similar backbone lentivirus, we expected 60–70% infection
efficiency. We observed IRBP-GFP expressing cells in the culture
plate from 4 days of infection and their numbers increased over
the next few weeks in vitro. To confirm the identity of the IRBP-
GFP expressing cells in the retinal cells derived from either hES
Figure 3. Cells in culture at two months after initiation of the
protocol expressed HuC/D (green, A) marking ganglion and
amacrine cells and Nrl (red, A) which labels rod photorecep-
tors. Photoreceptors were identified by the expression of Otx2
(green, B), Crx (E), recoverin (red, C) and AIPL1 (red, D). Cells also
expressed differentiated markers like rhodopsin (red, G) and S-opsin
(green, F). (H) Retinal pigmented epithelium was also generated from
the iPS cells and these cells expressed ZO-1 (inset). Nuclei stained with
DAPI in blue.
doi:10.1371/journal.pone.0008763.g003
Figure 4. IRBP-GFP infection of human retinal explant resulted
in GFP expression in photoreceptors as evidenced by co-
expression of Otx2 (red, A, A0), AIPL1 (white, A, A09), recoverin
(red, B, B0) and Blimp1 (white, B, B09). IRBP-GFP expression in iPS
cell-derived retinal cells. GFP cells co-expressed AIPL1 (red, C, C’), Nrl
(red, D, D’). Nuclei stained with DAPI in blue.
doi:10.1371/journal.pone.0008763.g004
iPS Cells Make Photoreceptors
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immuno-fluorescent analysis with the photoreceptors markers
AIPL1, rhodopsin, CRX and NRL (figure 4C-C9, D-D0). We
found that nearly 100% of the GFP cells were labeled for CRX
and the majority also expressed NRL, AIPL1 or rhodopsin. In
order to purify the IRBP-GFP-expressing cells from the live iPS
cell cultures, we subjected them to fluorescent-activated cell sorting
(FACS) (figure 6C). On average, 10% of all cells in the cultures
expressed IRBP-GFP. Following the FAC sorting, over 90%
(92.18% +/24.28) of the cells expressed the IRBP-GFP marker.
Additionally, all the GFP+ cells stained for CRX and most for
recoverin (figure 6A, B, D). Thus, retinal photoreceptors derived
from iPS cells and H-1 hES cells can be enriched using a
combination of IRBP-GFP lentivirus followed by FACS.
In our previous study, we found that retinal cells derived from
human ES cells would migrate into the retina and differentiate into
photoreceptors following transplantation to the sub-retinal space.
To determine whether iPS cell-derived photoreceptors would
incorporate into the retinas of mice following transplantation, we
used a similar approach. iPS cells were directed to a retinal fate
using our protocol and maintained in culture for an additional 4
weeks. The cells were then infected with the IRBP-GFP lentivirus
and maintained in culture for an additional one to two weeks.
Once a sufficient number of IRBP-GFP cells were present in the
live cultures, we dissociated the cells and subjected them to FACS.
The IRBP-GFP expressing population was then immediately
transplanted into the sub-retinal space of adult wild-type mice.
After a survival period of three weeks, the mice were euthanized
and the eyes were removed, fixed and sectioned. The transplanted
photoreceptors were identified using immuno-fluorescence for
GFP and other photoreceptor markers. We found that iPS derived
photoreceptors survived in the sub-retinal space over the three-
week period, though at a much lower survival rate than the
unsorted cells. We also found approximately 50 cells per eye that
had migrated into the outer nuclear layer and were similar in
appearance to hES derived photoreceptors following transplanta-
tion[2]. The iPSC-derived photoreceptors migrated well into the
ONL and expressed the photoreceptor markers Otx2, recoverin
and rhodopsin (figure 7A,B). These data further demonstrate the
ability of human iPSCs to differentiate into photoreceptors, and
further show that human iPS cell-derived photoreceptors can
survive and integrate into the retina after FACS purification and
transplantation.
Discussion
In this report we have shown that human iPS cells can be used
to generate retinal photoreceptors that can be purified by infecting
with a lentivirus that drives GFP from the IRBP promoter and
subsequent FACS. Our results show for the first time that human
photoreceptors derived from either ES cells or iPS cells can be
purified using a combination of photoreceptor-specific GFP vector
and fluorescent activated cell sorting. Together with previous
results that demonstrated the potential for ES cell derived
photoreceptors to integrate following transplantation and restore
light response to CRX 2/2 mice [2], the results presented in this
report further support the possibility that stem cell approaches can
lead to therapies for the treatment of retinal degenerations.
Three recent reports also show that other protocols used for
retinal differentiation of ES cells can be used for iPS cells derived
either from mouse or human to direct their differentiation to
retinal cells [16,17]. Hirami et al found that manipulations in Wnt
and nodal pathways were able to induce retinal gene expression in
20% of their cells in 2 of the 3 human iPS cell lines they tested.
They also showed that 14% of their colonies expressed Crx,
though it is unclear how many cells in each colony expressed the
marker. The same group also published another report using small
molecules that affect the same molecular pathways and found a
similar degree of retinal cell induction [18]. Meyer et al used a
different approach of manually selecting floating spheres which
had neural rosette morphology[17]. After manually selecting
retinal spheres, ,9% of the cells expressed Crx at 80 days, which
is comparable to what we see from our protocol when we assay all
cells in culture. In all cases, however, there is variability in the
response of a particular iPSC line to the induction protocol. It will
be interesting in the future to directly compare the same iPSCs
with these different protocols to determine whether specific iPSC
lines are not as responsive to differentiate as retinal cells, or
alternatively, particular iPSC lines might be better suited to
particular protocols of directed differentiation.
Human skin fibroblasts can be reprogrammed to a pluripotent
state using several different methods [6,8,9,19,20]. Our results
demonstrate that these reprogrammed fibroblasts can be directed
towards a retinal progenitor pathway with efficiency similar to that
of human ES cells. The presence of the pluripotency factors in
vector proviruses does not appear to interfere with the differen-
tiation of the cells to a retinal fate. In fact, we find that the protocol
we developed for ES cells is as effective in directing the iPS cells to
Figure 5. Microarray analysis of FACS sorted human fetal
retinal IRBP-GFP cells and 96 day unsorted fetal retinal cells.
The figure shows the heat map of the spot intensity comparison on the
microarray of the various photoreceptor and retinal progenitor genes.
doi:10.1371/journal.pone.0008763.g005
iPS Cells Make Photoreceptors
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with incomplete silencing of the transgenes in the iPSCs. This is
perhaps not surprising in light of recent evidence that iPSCs can
differentiate into many different types of mature lineages [7,12].
Nevertheless, more recent methods for deriving iPS cells do not
rely on viral integration of the inducing genes and may therefore
prove even more useful for the derivation of iPS cells for cell based
therapies [21,22,23,24].
Our findings may lead to the generation of human
photoreceptors from individuals with inherited retinal degener-
ations, like Retinitis Pigmentosa (RP) and the development of
additional models for these disorders. Although animal models
have been generated for several forms of RP, there are many
different mutations that cause this disease [25]. The ability to
make photoreceptors from iPS cells should allow the generation
of in-vitro models for these forms of RP. The iPSC-derived
photoreceptors may therefore be useful for screening for
compounds that will slow or prevent rod degeneration in these
individuals. Although the photoreceptors generated from iPS
cells or ES cells do not fully mature in vitro, the differentiation
of ES cells can be facilitated through transplantation into the
mouse retina, and a similar approach may be used for iPS cell
derived photoreceptors. In addition to RP, iPS derived
photoreceptors may be useful for developing therapies for
patients with early onset retinal degenerations. Developmental
disorders are particularly amenable to modeling with iPS cells.
Recent studies have shown that motor neurons derived from iPS
cells from patients with spinal muscular atrophy have been
shown to have selective motor neuron death [26]. Photorecep-
tors derived from iPS cells from patients with Leber’s congenital
amaurosis or Usher’s disease would be good candidates for a
similar approach.
We have also found that the photoreceptors derived from ES
cells and from iPS cells can be labeled in live cultures when
infected with a lentivirus that drives GFP expression from the
IRBP promoter sequences. The GFP expressing cells can be
purified by FACS technology to contain nearly 90% photorecep-
tors, as assessed with subsequent labeling with rod and cone
markers. The ability to purify the cells from undifferentiated
contaminants is critical in developing a safe cell-based therapy for
retinal degenerations. Earlier studies using less differentiated cell
for transplantation have found evidence of teratoma formation; by
comparison, we have never observed a teratoma following
transplantation in over 100 mice to date with photoreceptors
derived from ES cells using our directed differentiation protocol. A
similar approach has been used to successfully reduce the risk of
teratoma formation in transplantation of dopamine neurons
derived from iPS cells [27]. Thus, using the FACS sorted
photoreceptor cells will add an additional level of security against
the risk of teratoma formation in cell based therapies using hES
cells.
Photoreceptors derived from iPS cells can be transplanted and
integrate into the retina. The iPSC-derived photoreceptors
behaved very similarly to cells derived from human ES cells.
After transplantation to the sub-retinal space, the cells begin to
move into the retina of normal adult mice within a few weeks.
Cells assume positions throughout the outer nuclear layer, and
have protein expression pattern similar to mouse rod photorecep-
Figure 6. Fluorescent activated Cells sorting of human cells. Following FACS and fixation, upon immunostaining, GFP cells (A) expressed Crx
(red, B). (C) Representative FACS plots for GFP cells in BD Aria II. (D) Plot showing percentage of sorted cells expressing Crx and recoverin.
doi:10.1371/journal.pone.0008763.g006
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has shown that photoreceptors derived from human ES cells were
able to restore some light response to Crx 2/2 mice [2]. We
found that FAC sorted cells did not survive as well as unsorted cells
and so there were insufficient cells integrated into the retina for
functional restoration. Nevertheless, the demonstration that iPS
cells can develop into rods that survive and integrate after
transplantation to the adult retina provides hope that autologous
transplantation can be developed as a treatment for some forms of
retinal degeneration. While gene therapy and medical therapies
are being developed for the more common retinal degenerations,
such as macular degeneration, there are millions of individuals
with significant visual loss that would benefit from a cell-
replacement therapy. Our results demonstrate the proof of
principle that iPS cells derived from patients with retinal diseases
may be useful in such therapies.
Supporting Information
Figure S1 Lentivirus testing on mouse and chicken explant
retinas. (A) shows GFP expression from the IRBP-GFP lentivirus
in mouse retina in the photoreceptors as evidenced by co-staining
with recoverin (red). (B) Control EF1a-GFP lentivirus resulted in
GFP in all mouse retinal cells. (C), (D) show similar IRBP-GFP (C)
in chicken photoreceptors as confirmed by photoreceptor marker
visinin (red) while Ef1a-GFP (D) resulted in GFP in all chicken
retinal cells.
Found at: doi:10.1371/journal.pone.0008763.s001 (7.70 MB TIF)
Figure S2 PCR analysis to assess silencing of exogenous
pluripotency genes. Above, gel image shows the expression of
the 4 pluripotency genes used for the creation of the iPS cell lines
at passage 12 of undifferentiated cell culture as well as 4 weeks
following retinal induction. By the end of 4 weeks, Lin28 and
Nanog were completely silenced, while Oct4 was reduced
compared to undifferentiated cells while Sox2 was not silenced
at all.
Found at: doi:10.1371/journal.pone.0008763.s002 (0.38 MB TIF)
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